The probiotic potential of propionibacteria

Lactic Acid Bacteria Microbiological and Functional Aspects, Third Edition: Revised and Expanded

Volumn , Issue , 2004, Pages 159-174

  Ouwehand, Arthur C ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85056952933     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (89)

1. Jensen, O. Die hauptlinien des natürlichen bakteriensystems. Centralbl. Bakteriol. Hyg. II Abt. 1909, 22, 305–346.
2. Bernard, K.A.; Shuttleworth, L.; Munro, C.; Forbes-Faulkner, J.C.; Pitt, D.; Norton, J.H.; Thomas, A.D. Propionibacterium australiense sp. nov. derived from granulomatous bovine lesions. Anaerobe 2002, 8, 41–47.
3. Vorobjeva, L. Physiological peculiarities of propionibacteria—present facts and prospective applications. Sci. Prog. 2000, 83, 277–301.
4. Fröhlich-Wyder, M.-T.; Bachmann, H.-P.; Casey, M.G. Interaction between propionibacteria and starter/non-starter lactic acid bacteria in Swiss-type cheeses. Lait 2002, 82, 1–15.
5. Freudenreich, E.; Jensen, O. Über die im Emmentalerkäse stattfindende propionsäusegärung. Centralbl. Bakteriol. Hyg. II. Abt. 1906, 17, 529.
6. Stepaniak, L. Isolation and characterization of proline iminopeptidase from Propionibacterium freudenreichii ATCC 9614. Nahrung 2000, 44, 102–106.
7. Shaw, R.H.; Sherman, J.M. The production of volatile fatty acids and carbondioxide by propionic acid bacteria with special reference to their action in cheese. J. Dairy Sci. 1923, 6, 303–309.
8. Thierry, A.; Maillard, M.-B. Production of cheese flavour compounds derived from amino acid catabolism by Propionibacterium freudenreichii. Lait 2002, 82, 17–32.
9. Gorret, N.; Maubois, J.L.; Ghoul, M.; Engasser, J.M. Exopolysaccharide production by Propionibacterium acidipropionici on milk microfiltrate. J. Appl. Microbiol. 2001, 90, 779–787.
10. Glatz, B. The classical propionibacteria: their past, present, and future as industrial organisms. ASM News 1992, 58, 197–201.
11. Mays, T.D.; Fornili, P.N. Microbial co-culture production of propionic acid. 1988, US patent 4,794,080.
12. Ozadali, F.; Glatz, B.A.; Glatz, C.E. Fed-batch fermentation with and without on-line extraction for propionic and acetic acid production by Propionibacterium acidipropionici. Appl. Microbiol. Biotechnol. 1996, 44, 710–716.
13. Jack, R.W.; Tagg, J.R.; Ray, B. Bacteriocins of gram-positive bacteria. Microbiol. Rev. 1994, 59, 171–200.
14. Leversee, J.A.; Glatz, B.A. Detection of the bacteriocin propionicin PLG-1 with polyvalent anti-PLG-1 antiserum. Appl. Environ. Microbiol. 2001, 67, 2235–2239.
15. Holo, H.; Faye, T.; Brede, D.A.; Nilsen, T.; Ödegård, I.; Langsrud, T.; Brendehaug, J.; Nes, I.F. Bacteriocins of propionic acid bacteria. Lait 2002, 82, 59–68.
16. Miescher, S. Antimicrobial and autolytic systems of dairy propionibacteria. ETH: Zürich, 1999; Ph.D. thesis.
17. Ratnam, P.; Barefoot, S.F.; Prince, I.U.; Bodine, A.B.; McCaskill, L.H. Partial purification of the bacteriocin produced by Propionibacterium jensenii B1264. Lait 1999, 79, 125–136.
18. Grinstead, D.A.; Barefoot, S.F. Jenseniin, G. A heat stable bacteriocin produced by Propionibacterium jensenii P126. Appl. Environ. Microbiol. 1992, 58, 215–220.
19. Ekinci, F.Y.; Barefoot, S.F. Production of bacteriocin jenseniin G by Propionibacterium is pH sensitive. Lett. Appl. Microbiol. 1999, 29, 176–180.
20. Ramanathan, S.; Read, G.; Cutting, W. Purification of propionin, an antiviral agent from propionbacteria. Proc. Soc. Exp. Biol. Med. 1966, 123, 271–273.
21. Ramanathan, S.; Wolynec, C.; Cutting, W. Antiviral principles of propionibacteriaisolation and activity of propionins B and C. Proc. Soc. Exp. Biol. Med. 1968, 129, 73–77.
22. Pattison, T.-L.; von Holly, A. Effect of selected natural antimicrobials on baker’s yeast activity. Lett. Appl. Microbiol. 2001, 33, 211–215.
23. Luck, E.; Oeser, H.; Remmert, K.H.; Sabel, J. On the nonexistence of propionic acid in various kinds of breads. Z. Lebensm. Unters. Forsch. 1975, 158, 127–129.
24. Ayres, J.W.; Sandine, W.E.; Weber, G.H. Preserving Foods using Metabolites of Propionibacteria other than Propionic Acid. U.S. patent 5,096,718, 1992.
25. Al-Zoreky, N.; Ayres, J.W.; Sandine, W.E. Characterization of propionibacterial growth metabolites inhibitory for gram negative bacteria. Cult. Dairy Prod. J. 1993, 28, 4–13.
26. Mäyrä-Mäkinen, A.; Suomalainen, T. Lactobacillus casei ssp. rhamnosus, Bacterial Preparations Comprising Said Strain, and use of Said Strain and Preparations for the Controlling of Yeast and Moulds. U.S. patent 5,378,458, 1995.
27. Boudreaux, D.P.; Matrozza, M.A. Composition for Extending the Shelf Life of Processed Meats. U.S. patent 5,219,603, 1993.
28. Tomes, N.J. Bacterial Treatment to Preserve Silage. U.S. patent 4,981,705, 1991.
29. Barefoot, S.F.; Ratnam, P. Composition and Method for Treating Bacterial Infection. U.S. patent 6,221,847, 2001.
30. Macfarlane, G.T.; Cummings, J.H.; Allison, C. Protein degradation by human intestinal bacteria. J. Gen. Microbiol. 1986, 132, 1647–1656.
31. Moore, W.E.C.; Holdeman, L.V. Human fecal flora: the normal flora of 20 Japanese- Hawaiians. Appl. Microbiol. 1974, 27, 961–979.
32. Bouglé, D.; Roland, N.; Lebeurrier, F.; Arhan, P. Effect of propionibacteria supplementation on fecal bifidobacteria and segmental colonic transit time in healthy human subjects. Scand. J. Gastroenterol. 1999, 34, 144–148.
33. McFarland, L.V. Normal flora: diversity and functions. Microb. Ecol. Health Dis. 2000, 12, 193–207.
34. Mantere-Alhonen, S. On the survival of a Propionibacterium freudenreichii - culture during in vitro gastric digestion. Meijeritiet Aikak 1983, 61, 19–23.
35. Warminska-Radyko, I.; Laniewska-Moroz, L.; Babuchowski, A. Possibilities for stimulation of Bifidobacterium growth by propionibacteria. Lait 2002, 82, 113–121.
36. Zárate, G.; Pérez Chaia, A.; González, S.; Oliver, G. Viability and b-galactosidase activity of dairy propionibacteria subjected to digestion by artificial gastric and intestinal fluids. J. Food Prot. 2000, 63, 1214–1221.
37. Jan, G.; Rouault, A.; Maubois J-L. Acid stress susceptibility and acid adaptation of Propionibacterium freudenreichii subsp. shermanii. Lait 2000, 80, 325–336.
38. Zárate, G.; Gonzalez, S.; Pérez Chaia, A.; Oliver, G. Effect of bile on the b-galactosidase activity of dairy propionibacteria. Lait 2000, 80, 267–276.
39. Mantere-Alhonen, S. Die Propionibakterien der Molkereiindustrie als Darmkanalmikroben. Meijeritiet Aikak 1982, 40, 1–95.
40. Pérez-Chaia, A.; Nader de Macias, M.E.; Oliver, G. Propionibacteria in the gut: effect on some metabolic activities of the host. Lait 1995, 75, 435–445.
41. Ouwehand, A.C.; Suomalainen, T.; Tölkkö, S.; Salminen, S. In vitro adhesion of propionic acid bacteria to human intestinal mucus. Lait 2002, 82, 123–130.
42. Lehto, E.M.; Salminen, S. Adhesion of two Lactobacillus strains, one Lactococcus and one Propionibacterium to cultured human intestinal Caco-2 cell line. Biosc. Microflora. 1997, 16, 13–17.
43. Ouwehand, A.C.; Båtsman, A.; Salminen, S. Probiotics for the skin: a new area of potential application?. Lett. Appl. Microbiol. 2003, 36, 327–332.
44. Zárate, G.; Morita de Ambrosini, V.I.; Perez Chaia, A.; González, S.N. Adhesion of propionibacteria to intestinal epithelial tissue in vitro and in vivo. J. Food Prot. 2002, 65, 534–539.
45. Kaneko, T.; Mori, H.; Iwata, M.; Meguro, S. Growth stimulator for bifidobacteria produced by Propionibacterium freudenreichii and several intestinal bacteria. J. Dairy Sci. 1994, 77, 393–404.
46. Hartemink, R.; Rombouts, F.M. Comparison of media for the detection of bifidobacteria, lactobacilli and total anaerobes from faecal samples. J. Microbiol. Meth. 1999, 36, 181–192.
47. Mori, H.; Sato, Y.; Taketomo, N.; Kamiyama, T.; Yoshiyama, Y.; Meguro, S.; Sato, H.; Kaneko, T. Isolation and structural identification of bifidogenic growth stimulator produced by Propionibacterium freudenreichii. J. Dairy Sci. 1997, 80, 1959–1964.
48. Sidorchuk, I.I.; Bondarenko, V.M. Selection of a biologically active mutant of Propionibacterium shermanii and the possibility of its use in complex therapy of enteral dysbiosis. J. Hyg. Epidemiol. Microbiol. Immunol. 1984, 28, 331–338.
49. Piveteau, P.G.; O’Callaghan, J.; Lyons, B.; Condon, S.; Cogan, T.M. Characterisation of the stimulants produced by Lactobacillus helveticus in milk for Propionibacterium freudenreichii. Lait 2002, 82, 69–80.
50. Hata, Y.; Yamamoto, M.; Ohni, M.; Nakajima, K.; Nakamura, Y.; Takano, T. A placebocontrolled study of the effect of sour milk on blood pressure in hypertensive subjects. Am. J. Clin. Nutr. 1996, 64, 767–771.
51. Pérez Chaia, A.; Zárate G.; Oliver, G. The probiotic properties of propionibacteria. Lait 1999, 79, 175–185.
52. Ouwehand, A.C.; Lagström, H.; Suomalainen, T.; Salminen, S. The effect of probiotics on constipation, faecal azoreductase activity and faecal mucins. Ann. Nutr. Metab. 2002, 46, 159–162.
53. El-Nezami, H.; Mykkänen, H.; Kankaanpää, P.; Suomalainen, T.; Salminen, S.; Ahokas, J. Ability of a mixture of Lactobacillus and Propionibacterium to influence the faecal aflatoxin content in healthy Egyptian volunteers: a pilot study. Biosci. Microflora. 2000, 19, 41–45.
54. Wolever, T.M.S.; Spadafora, P.; Eshuis, H. Interaction between colonic acetate and propionate in humans. Am. J. Clin. Nutr. 1991, 53, 681–687.
55. MacDonald, H.B. Conjugated linoleic acid and disease prevention: a review of current knowledge. J. Am. Coll. Nutr. 2000, 19, 111S–118S.
56. Kelly, G.S. Conjugated linoleic acid: a review. Altern. Med. Rev. 2001, 6, 367–382.
57. Belury, M.A. Dietary conjugated linoleic acid in health: physiological effects and mechanisms of action. Annu. Rev. Nutr. 2002, 22, 505–531.
58. Jiang, J.; Björck, L.; Fondén, R. Production of conjugated linoleic acid by dairy starter cultures. J. Appl. Microbiol. 1998, 85, 95–102.
59. Rainio, A.; Vahvaselkä, M.; Suomalainen, T.; Laakso, S. Production of conjugated linoleic acid by Propionibacterium freudenreichii ssp. shermanii. Lait 2002, 82, 91–101.
60. Hunik, J.H. Improved Process for the Production of Vitamin B12; patent WO 00/37669.
61. Hugenholtz, J.; Hunik, J.; Santos, H.; Smid, E. Nutraceutical production by propionibacteria. Lait 2002, 82, 103–112.
62. Forssén, K.M.; Jägerstad, M.I.; Wigertz, K.; Witthöft, C.M. Folates and dairy products: a critical update. J. Am. Coll. Nutr. 2000, 19, 100S–110S.
63. Vuorinen, A.; Mantere-Alhonen, S. On trace elements in Propionibacterium freudenreichii - mass. Meijeritiet. Aikak. 1982, 40, 53–59.
64. de Vaux, A.; Morrison, M.; Hutkins, R.W. Displacement of Escherichia coli O157:H7 from rumen medium containing prebiotic sugars. Appl. Environ. Microbiol. 2002, 68, 519–524.
65. Rinta-Koski, M.; Beasley, S.; Montonen, L.; Mantere-Alhonen, S. Propionibacteria isolated from rumen used as possible probiotics together with bifidobacteria. Milchwissenschaft 2001, 56, 11–13.
66. Tsuchida, T.; Fujiwara, H.; Tsuji, Y.; Hamaoka, T. Inhibitory effect of Propionibacterium acnes-activated macrophages on the tumor metastasis enhanced by tumor-specific immunosuppression. Gann 1981, 72, 205–212.
67. Pulverer, G.; Ko, H.L.; Tungga, L.; Beuth, J.; Jeljaszewicz, J. Combined immunomodulation (Propionibacterium avidum KP-40) and lectin blocking (D-galactose) prevents liver tumor colonization in BALB/c-mice. Zentralbl. Bakteriol. 1994, 281, 491–494.
68. Isenberg, J.; Ko, H.; Pulverer, G.; Grundmann, R.; Stützer, H.; Pichlmaier, H. Preoperative immunostimulation by Propionibacterium granulosum KP-45 in colorectal cancer. Anticancer. Res. 1994, 14, 1399–1404.
69. Panangala, V.S.; Haynes, T.B.; Schultz, R.D.; Mitra, A. Immunomodulation with killed Propionibacterium acnes in guinea pigs simulaneously vaccinated with Brucella abortus strain19. Vet. Immunol. Immunopathol. 1986, 13, 71–84.
70. Szmigielski, S.; Kobus, M.; Gil, J.; Jeljaszewicz, J.; Pulverer, G. Protection and therapy of mice with acute and chronic experimental virus infections with Propionibacterium granulosum KP-45. Zentralbl. Bakteriol. A 1980, 248, 286–295.
71. Kirjavainen, P.V.; El-Nezami, H.S.; Salminen, S.J.; Ahokas, J.T.; Wright PFA. Effects of orally administered viable Lactobacillus rhamnosus GG and Propionibacterium freudenreichii subsp. shermanii JS on mouse lymphocyte proliferation. Clin. Diag. Lab. Immunol. 1999, 6, 799–802.
72. Jan, G.; Belzacq, A.-S.; Haouzi, D.; Rouault, A.; Métivier, D.; Kroemer, G.; Brenner, C. Propionibacteria induce apoptosis of colorectal carcinoma cells via short-chain fatty acids acting on mitochondria. Cell. Death Diff. 2002, 9, 179–188.
73. Pottkamper, M.; Randerath, O.; Beuth, J.; Pulverer, G. Influence of propionibacterium avidum KP-40 on the cellular immune system after intensive sport activity. Zentralbl. Bakteriol. 1996, 284, 367–371.
74. Dupuis, C.; Corr, C.; Boyaval, P. Proteinase activity of dairy propionibacteria. Appl. Microbiol. Biotechnol. 1995, 7, 750–755.
75. Hughes, R.; Rowland, I.R. Metabolic activities of the gut microflora in relation to cancer. Microb. Ecol. Health Dis. 2000, 11, 179–185.
76. Allaker, R.P.; Greenam, J.; Osborne, R.H. The production of inflammatory compounds by Propionibacterium acnes and other skin organisms. Br. J. Dermatol. 1987, 117, 175–183.
77. Toyoda, M.; Morohashi, M. Pathogenesis of acne. Med. Electron. Microsc. 2001, 34, 29–40.
78. Wu, X.T.; Xiao, L.J.; Li, X.Q.; Li, J.S. Detection of bacterial DNA from cholesterol gallstones by nested primers polymerase chain reaction. World J. Gastroenterol. 1998, 4, 234–237.
79. Jakab, E.; Zbinden, R.; Gubler, J.; Ruef, C.; von Graevenitz, A.; Krause, M. Severe infections caused by Propionibacterium acnes: an underestimated pathogen in late postoperative infections. Yale. J. Biol. Med. 1996, 69, 477–482.
80. Brook, I.; Frazier, E.H. Infections caused by Proionibacterium species. Rev. Infect. Dis. 1991, 13, 819–822.
81. Kotilainen, P.; Merilahti-Palo, R.; Lehtonen, O.P.; Manner, I.; Helander, I.; Mottonen, T.; Rintala, E. Propionibacterium acnes isolated from sternal osteitis in a patient with SAPHO syndrome. J. Rheumatol. 1996, 23, 1302–1304.
82. Daly, C.; Mitchell, D.; Grossberg, D.; Highfield, J.; Stewart, D. Bacteraemia caused by periodontal probing. Aust. Dent. J. 1998, 42, 77–80.
83. Brook, I. Meniningitis and shunt infection caused by anaerobic bacteria in children. Pediatr. Neurol. 2002, 26, 99–105.
84. Braks, M.A.H.; Anderson, R.A.; Knols, B.G.J. Infochemicals in musquito host selection: human skin microflora and Plasmodium parasites. Parasitol. Today 1999, 15, 409–413.
85. Fujimura, S.; Nakamura, T. Purification and properties of a bacteriocin-like substance (acnecin) of oral Propionibacterium acnes. Antimicrob. Agents Chemother. 1978, 14, 893–898.
86. Ayres, J.W.; Sandine, W.E.; Weber, G.H. Propionibacteria Peptide Microcin. U.S. patent 5,635,484, 1997.
87. Faye, T.; Brede, D.A.; Langsrud, T.; Nes, I.F.; Holo, H. An antimicrobial peptide is produced by extracellular processing of a protein from Propionibacterium jensenii. J. Bacteriol. 2002, 184, 3649–3656.
88. Faye, T.; Langsrud, T.; Nes, I.F.; Holo, H. Biochemical and genetic charcterization of propionicin T1, a new bacteriocin from Propionibacterium thoenii. Appl. Environ. Microbiol. 2000, 66, 4230–4236.
89. Miescher, S.; Stierli, M.P.; Teuber, M.; Meile, L. Propionicin SM1, a bacteriocin from Propionibacterium jensenii DF1: isolation and characterization of the protein and its gene. Syst. Appl. Microbiol. 2000, 23, 174–184.